Recent Research from the ODPRN

Spending on hepatitis C antivirals in the United States and Canada, 2014 to 2018

This case-study explores differences in drug spending between Canada and the US to compare drug expenditures on hepatitis C virus medications.

Characteristics of high drug-cost beneficiaries across Canada: A cross-sectional pan-Canadian analysis

This study describes the characteristics of high drug-cost beneficiaries (the top 5% of public drug program beneficiaries based on annual costs) in 9 provinces across Canada, to inform current planning around national drug strategies.

Oxycodone, hydromorphone, and the risk of suicide: A retrospective population-based case-control study

This study explores whether oxycodone and hydromorphone are differentially associated with suicide.

Current and prospective utilization of innovator biologics and biosimilars in Ontario

This report describes the current and prospective utilization patterns and expenditures of innovator biologics and biosimilars through the public drug program in Ontario, Canada.

Impact of a publicly funded herpes zoster immunization program on the burden of disease in Ontario, Canada: a population-based study

This study evaluates the impact of both the private availability of a live attenuated vaccine for herpes zoster and the introduction of an associated publicly funded immunization program on the burden of herpes zoster among Ontario residents. 

Additional Resources